# Brimonidine Eye Drops in the Prevention of Myopia Progression

> **NCT06996236** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal** · enrollment: 40 (estimated)

## Conditions studied

- Myopia

## Interventions

- **DRUG:** Treatment with brimonidine eye drops 0.025%

## Key facts

- **NCT ID:** NCT06996236
- **Lead sponsor:** Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-07
- **Primary completion:** 2026-07
- **Final completion:** 2027-07
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06996236

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06996236, "Brimonidine Eye Drops in the Prevention of Myopia Progression". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06996236. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*